Get notified when HRL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Asset Impairment (new) — Company recorded $48.2M impairment on Garudafood equity investment due to severity and duration of excess carrying value vs. fair value.
Hormel Q3 EPS falls 67% to $0.11 on Brazil exit, Indonesia impairment, and litigation
Filed August 27, 2026 · Period ending July 26, 2026 · Compared to 10-Q Aug 28, 2025 · ~1 min read
Key Changes
-
high
Diluted EPS fell 67% to $0.11 in Q3 FY26 from $0.33 in Q3 FY25, driven by a $56M loss on Brazil divestiture, a $48M impairment of the Garudafood equity investment, and a $38M Turkey antitrust settlement. Adjusted EPS (excluding these items) rose 6% to $0.37.
MD&A: Earnings verify on EDGAR → -
high
Company agreed to sell Brazil operations (Ceratti brand) for $22.1M cash in July 2026, recognizing a $56M pre-tax loss including accumulated FX translation losses. Also divested whole-bird turkey business for $61.2M ($21.2M cash + $40M note), recording a $61M loss.
Notes: Divestitures verify on EDGAR → -
high
Garudafood equity investment impaired by $48M in Q3 FY26 as quoted market value fell 26% to $184M. Despite positive equity earnings, severity and duration of the decline indicated the loss was no longer temporary.
Notes: Equity Investments verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Partner
Trade HRL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 28, 2026 · How we verify